博客与新闻MYmAb Biologics 获得 GVPD 130 万令吉用于组织微阵列开发MYmAb Biologics Receives RM 1.3 Million… main.pillarsmedia@gmail.com8 月 8, 2024
JournalSusceptibility to SARS-CoV-2 omicronSusceptibility to SARS-CoV-2 omicron fo… main.pillarsmedia@gmail.com5 月 5, 2024